ACTRN12613001066774撤回2 期
TROG13.02: A phase II single arm trial of stereotactic image guided radiotherapy for colo-rectal liver metastases to determine if it can be performed in a multidisciplinary setting with acceptable toxicity (Liver Image Guided High Dose Radiation Therapy)
Trans Tasman Radiation Oncology Group (TROG)0 个研究点目标入组 30 人开始时间: 2013年9月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients with up to 5 medically or surgically inoperable colo-rectal cancer liver metastases with a maximum metastasis size of 8cm in whom progression of the liver disease is expected to cause significant morbidity are eligible for the trial
排除标准
- •Patients with previous upper abdominal radiotherapy or inadequate liver reserve (<800mL of normal liver) will be excluded from the trial.
研究者
相似试验
进行中（未招募）
2 期
Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney, a Phase II Clinical Trial (FASTRACK II)Renal cell carcinoma with a single lesion within a kidneyPrimary kidney tumour intact and no more than 5 documented metastasesCancer - KidneyACTRN12615001181594Trans Tasman Radiation Oncology Group (TROG)71
进行中（未招募）
1 期
Prostate cancer with OligometaSTatic relapse: Combining stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736), a randomized phase II trialCTIS2024-513207-13-00Institut De Cancerologie De L Ouest96
进行中（未招募）
1 期
A phase 2 trial for patients with metastatic prostate cancer to study treatment with nivolumab and ipilimumab with or without radiotherapymetastatic castration-resistant prostate cancerMedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036920Term: Prostate cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10076506Term: Castration-resistant prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003461-34-DKDepartment of Oncology, Herlev & Gentofte Hospital90
招募中
1 期
A clinical study to test the effect of niraparib and immunotherapy, for patients with small cell lung cancer (SCLC) that is positive for SLFN11.Extensive-disease small cell lung cancer and high SLFN11-expressionMedDRA version: 21.1Level: PTClassification code: 10041067Term: Small cell lung cancer Class: 100000004864MedDRA version: 21.1Level: PTClassification code: 10041068Term: Small cell lung cancer extensive stage Class: 100000004864MedDRA version: 20.0Level: LLTClassification code: 10025044Term: Lung cancer Class: 10029104CTIS2022-502092-33-00ETOP IBCSG Partners Foundation44
已完成
不适用
Phase II trial of second course of spine stereotactic body radiotherapyspinal metastasesJPRN-UMIN000043319Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital20